Not exact matches
Remarkably, the
researchers also found that blocking this protein in mice protected them from the lethal effects of dengue virus infection, an important finding given that an effective
vaccine against dengue has remained elusive, partly
because there are four serotypes of the virus that cause disease.
Some
researchers remain skeptical of the
vaccine approach
because it doesn't treat the underlying physiology of addiction.
The
researchers also believe that their
vaccines would be safer than DNA
vaccines, another alternative that scientists are pursuing,
because unlike DNA, RNA can not be integrated into the host genome and cause mutations.
A new HCV infection is effectively treated with direct - acting antiviral drugs, but the
researchers say a preventive
vaccine is needed to control what they call an HCV pandemic
because as many as 50 percent of people infected are unaware that they carry the virus, putting others at risk of infection.
Because Ebola diagnostics and some therapeutics like
vaccines are based on the specific viral sequence, it is important for
researchers to have the most up - to - date virus genome sequence possible.
Researchers suspect an autoimmune reaction is to blame
because many people who develop narcolepsy — and just about everyone with the
vaccine - associated form — have a specific variant in a gene in the HLA family, which helps the body distinguish its own proteins from those made by microbial invaders.
Because heroin is too small a molecule to induce antibodies on its own,
researchers work closely with organic chemists to create the structural analog (hapten) that is joined to a carrier protein and used in the
vaccine.
Whitehead and the other
researchers said that in the case of dengue, the testing was warranted
because they knew that the
vaccine appeared to be effective at preventing dengue 1, 3 and 4 viruses through previous testing but needed to learn more about its impact on dengue 2 before proceeding to larger trials that could take three to 10 years and cost tens of millions of dollars.
The trials would be for proof of concept, to show whether
researchers can, for the first time in humans, stimulate the right B cells to start the process of making broadly neutralizing antibodies, long considered the «holy grail» of HIV
vaccine research
because they defend against infection by a broad spectrum of HIV strains.
Influenza vaccination rates in children may have decreased for the 2016 - 2017 influenza season
because of a recommendation by the Centers for Disease Control and Prevention (CDC) that the nasal spray version of the
vaccine not be used, according to Penn State College of Medicine
researchers.
CBCNews.ca reported that in his affidavit, the
researcher told officers he was working on a
vaccine for the Ebola virus and HIV and that on his last day at the lab, he stole 22 vials to use at his new job in the U.S.
because he did not want to have to start from the beginning with respect to his research.